List of Excipients in API PITAVASTATIN CALCIUM
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing PITAVASTATIN CALCIUM
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Kowa Pharmaceuticals America Inc | LIVALO | pitavastatin calcium | 66869-104 | HYPROMELLOSE | |
| Kowa Pharmaceuticals America Inc | LIVALO | pitavastatin calcium | 66869-104 | LACTOSE MONOHYDRATE | |
| Kowa Pharmaceuticals America Inc | LIVALO | pitavastatin calcium | 66869-104 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | |
| Kowa Pharmaceuticals America Inc | LIVALO | pitavastatin calcium | 66869-104 | MAGNESIUM ALUMINOMETASILICATE TYPE IB | |
| Kowa Pharmaceuticals America Inc | LIVALO | pitavastatin calcium | 66869-104 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing PITAVASTATIN CALCIUM
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 | CELLULOSE, MICROCRYSTALLINE |
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 | CROSPOVIDONE |
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 | HYPROMELLOSES |
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 | LACTOSE MONOHYDRATE |
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 | MAGNESIUM OXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for PITAVASTATIN CALCIUM
Excipient focus: CALCIUM CARBONATE
PITAVASTATIN CALCIUM drug variants containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | pitavastatin calcium | 68382-481 |
| Zydus Lifesciences Limited | pitavastatin calcium | 70771-1784 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing CALCIUM CARBONATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
PITAVASTATIN CALCIUM drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSPOVIDONE
PITAVASTATIN CALCIUM drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| Zydus Pharmaceuticals USA Inc | pitavastatin calcium | 68382-481 |
| Zydus Lifesciences Limited | pitavastatin calcium | 70771-1784 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing CROSPOVIDONE
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
PITAVASTATIN CALCIUM drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | pitavastatin calcium | 68180-735 |
| QUINN PHARMACEUTICALS LLC | pitavastatin calcium | 69076-030 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
PITAVASTATIN CALCIUM drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
PITAVASTATIN CALCIUM drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
PITAVASTATIN CALCIUM drug variants containing HYPROMELLOSES
PITAVASTATIN CALCIUM drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
PITAVASTATIN CALCIUM drug variants containing LACTOSE MONOHYDRATE
PITAVASTATIN CALCIUM drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
PITAVASTATIN CALCIUM drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE I-B
PITAVASTATIN CALCIUM drug variants containing MAGNESIUM ALUMINOMETASILICATE TYPE I-B
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | pitavastatin calcium | 68180-735 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing MAGNESIUM ALUMINOMETASILICATE TYPE I-B
Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE IB
PITAVASTATIN CALCIUM drug variants containing MAGNESIUM ALUMINOMETASILICATE TYPE IB
| Company | Ingredient | NDC |
|---|---|---|
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing MAGNESIUM ALUMINOMETASILICATE TYPE IB
Excipient focus: MAGNESIUM CARBONATE
PITAVASTATIN CALCIUM drug variants containing MAGNESIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| QUINN PHARMACEUTICALS LLC | pitavastatin calcium | 69076-030 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing MAGNESIUM CARBONATE
Excipient focus: MAGNESIUM OXIDE
PITAVASTATIN CALCIUM drug variants containing MAGNESIUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing MAGNESIUM OXIDE
Excipient focus: MAGNESIUM STEARATE
PITAVASTATIN CALCIUM drug variants containing MAGNESIUM STEARATE
PITAVASTATIN CALCIUM drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
PITAVASTATIN CALCIUM drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| Zydus Pharmaceuticals USA Inc | pitavastatin calcium | 68382-481 |
| Zydus Lifesciences Limited | pitavastatin calcium | 70771-1784 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOLS
PITAVASTATIN CALCIUM drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| QUINN PHARMACEUTICALS LLC | pitavastatin calcium | 69076-030 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POVIDONE K30
PITAVASTATIN CALCIUM drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
PITAVASTATIN CALCIUM drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| Lupin Pharmaceuticals Inc | pitavastatin calcium | 68180-735 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CARBONATE
PITAVASTATIN CALCIUM drug variants containing SODIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| Zydus Pharmaceuticals USA Inc | pitavastatin calcium | 68382-481 |
| Zydus Lifesciences Limited | pitavastatin calcium | 70771-1784 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing SODIUM CARBONATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
PITAVASTATIN CALCIUM drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TALC
PITAVASTATIN CALCIUM drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Upsher-Smith Laboratories LLC | pitavastatin calcium | 0832-6048 |
| Zydus Pharmaceuticals USA Inc | pitavastatin calcium | 68382-481 |
| QUINN PHARMACEUTICALS LLC | pitavastatin calcium | 69076-030 |
| Zydus Lifesciences Limited | pitavastatin calcium | 70771-1784 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
PITAVASTATIN CALCIUM drug variants containing TITANIUM DIOXIDE
PITAVASTATIN CALCIUM drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
PITAVASTATIN CALCIUM drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | pitavastatin calcium | 0480-3632 |
| AvKARE | pitavastatin calcium | 42291-906 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing TRIACETIN
Excipient focus: TRIETHYL CITRATE
PITAVASTATIN CALCIUM drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | pitavastatin calcium | 31722-875 |
| Kowa Pharmaceuticals America Inc | pitavastatin calcium | 66869-104 |
| Lupin Pharmaceuticals Inc | pitavastatin calcium | 68180-735 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
PITAVASTATIN CALCIUM drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| QUINN PHARMACEUTICALS LLC | pitavastatin calcium | 69076-030 |
| >Company | >Ingredient | >NDC |
PITAVASTATIN CALCIUM drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
